Clinical Trial Update: Safety Study of Pelvic and Prostatic SIB-IMRT With Long-term Androgen Deprivation for High Risk Localized Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 safety trial evaluating pelvic and prostatic SIB-IMRT with long-term androgen deprivation in high-risk localized prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Centre Georges Francois Leclerc | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED